ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drossos, G.
Right arrow Articles by Westaby, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drossos, G.
Right arrow Articles by Westaby, S.

Ann Thorac Surg 1995;59:169-172
© 1995 The Society of Thoracic Surgeons

Deferoxamine Cardioplegia Reduces Superoxide Radical Production in Human Myocardium

George Drossos, MD, Antigone Lazou, PhD, Photis Panagopoulos, MD, Stephen Westaby, FRCS

Ahepa General Hospital, University of Thessaloniki, Thessaloniki, Greece

Accepted for publication August 8, 1994.

Recent studies have demonstrated enhanced myocardial protection during ischemia using the oxygen free radical scavenger, deferoxamine. This effect of deferoxamine may be related either to its iron-chelating property or to intervention in an iron-independent mechanism. We tested the latter by determining the rate of superoxide anion production and the degree of lipid peroxidation in human myocardial tissue after including deferoxamine in cardioplegic solution. Fourteen patients who underwent aortic, mitral, or double valve replacement were included in the study. The mean value for superoxide radical production was 59.8 ± 17.0 nmol • min-1 • g-1 for the control group (group C; n = 7) and 21.3 ± 8.1 (p < 0.001) for the deferoxamine-treated group (group D; n = 7). The mean value for thiobarbituric reactive substances was 80.00 ± 23.4 in group C and 38.7 ± 23.8 nmol • min-1 • g-1 in group D (p < 0.01). In conclusion, deferoxamine appears to have a moderating effect on the biochemical markers of ischemia reperfusion injury. Its scavenging effect on superoxide anion could play a role in the cellular defense against oxygen radicals during cardiac operations.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
L. G. Kevin, E. Novalija, and D. F. Stowe
Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice
Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. A. Paraskevaidis, E. K. Iliodromitis, D. Vlahakos, D. P. Tsiapras, A. Nikolaidis, A. Marathias, A. Michalis, and D. Th. Kremastinos
Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance
Eur. Heart J., February 1, 2005; 26(3): 263 - 270.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
V. S. Chekanov, V. Nikolaychik, M. A. Maternowski, R. Mehran, M. B. Leon, M. Adamian, J. Moses, G. Dangas, N. Kipshidze, and M. Akhtar
Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model
Ann. Thorac. Surg., January 1, 2003; 75(1): 184 - 189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Schumann, B. Borch-Iohnsen, M. W Hentze, and J. J. Marx
Tolerable upper intakes for dietary iron set by the US Food and Nutrition Board
Am. J. Clinical Nutrition, September 1, 2002; 76(3): 499 - 500.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Karck, S. Tanaka, E. Berenshtein, C. Sturm, A. Haverich, and M. Chevion
The push-and-pull mechanism to scavenge redox-active transition metals: A novel concept in myocardial protection
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1169 - 1178.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. S. Steingrub
Novel Insights Into the Pathogenesis and Therapy of Circulatory Shock
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 31 - 45.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E.-X. Lu, S.-X. Chen, M.-D. Yuan, T.-H. Hu, H.-C. Zhou, W.-J. Luo, G.-H. Li, and L.-M. Xu
Preconditioning Improves Myocardial Preservation in Patients Undergoing Open Heart Operations
Ann. Thorac. Surg., November 1, 1997; 64(5): 1320 - 1324.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
S. C. Nicholson, M. Squier, D. J. P. Ferguson, Z. Nagy, S. Westaby, and R. D. Evans
Effect of Desferrioxamine Cardioplegia on Ischemia-Reperfusion Injury in Isolated Rat Heart
Ann. Thorac. Surg., April 1, 1997; 63(4): 1003 - 1011.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. C. Cleveland Jr, D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken
Optimal Myocardial Preservation: Cooling, Cardioplegia, and Conditioning
Ann. Thorac. Surg., February 1, 1996; 61(2): 760 - 768.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.